Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Akebia Therapeutics
9987 Carver Road, Suite 420
Cincinnati, OH 45242
Phone: 513-985-1920
http://akebia.com/

Akebia Therapeutics is a discovery and development company focused on the treatment of chronic anemia. Akebia's lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in Phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimulate endogenous EPO production.

Key Contact
Name
Joseph H. Gardner, PhD
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
06/04/13 $41,000,000 Series C AgeChem Venture Fund
Kearny Venture Partners
Novartis Venture Funds
Novo A/S
Satter Investment Management
Triathlon Medical Ventures
Venture Investors
undisclosed